(Q40613344)

22 September 2017

title

The effect of oral 13-cis-retinoic acid on retinal redetachment after surgical repair in eyes with proliferative vitreoretinopathy (English)

1 reference

22 September 2017

Fekrat S

1

1 reference

22 September 2017

de Juan E Jr

series ordinal

2

1 reference

22 September 2017

Campochiaro PA

series ordinal

3

1 reference

22 September 2017

publication date

1 March 1995

1 reference

22 September 2017

1 reference

22 September 2017

volume

102

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

412-418

1 reference

The classification of retinal detachment with proliferative vitreoretinopathy

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

Changing Concepts of Failures After Retinal Detachment Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

Clinical risk factors for proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

Pigment Epithelial Proliferation in Human Retinal Detachment with Massive Periretinal Proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

Epiretinal and vitreous membranes. Comparative study of 56 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

Antiproliferative drugs in the treatment of experimental proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

Effect of adriamycin on experimental proliferative vitreoretinopathy in the rabbit.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

Inhibition of Intraocular Proliferations with Intravitreal Corticosteriods

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

Factors modulating the effect of retinoids on cultured retinal pigment epithelial cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

An updated classification of retinal detachment with proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

Scleral buckling for retinal detachments complicated by periretinal proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

A new concept for vitreous surgery. 3. Indications and results

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

The use of silicone oil following failed vitrectomy for retinal detachment with advanced proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

Silicone oil for advanced proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

Long-term results of successful vitrectomy with silicone oil for advanced proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

Causes of failure after repeat vitreoretinal surgery for recurrent proliferative vitreoretinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

Treatment of corneal xerophthalmia with topical retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

Healing of experimental corneal wounds treated with topically applied retinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

A human retinoic acid receptor which belongs to the family of nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

Identification of a receptor for the morphogen retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

Identification of a second human retinoic acid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

Retinoid metabolism in cultured human retinal pigment epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2931007-X

7 January 2021

10.1016/S0161-6420(95)31007-X

Identifiers

DOI

1 reference

22 September 2017

1 reference